Skip to content
drillr.ai
Sign up

BLTE

BELITE BIO, INC

NASDAQ · Healthcare · Biotechnology · US

$150.28
+1.05%
Ask drillr
0
Insider buys (3m)
48
Insider sells (3m)
-$30.6M
Net value (3m)
-6.2%
Price return (3m)
Form 4 filings
DateInsiderActivitySharesPrice
Oct 5, 2026Scholl Hendrik Peter · officer: Chief Medical OfficerSale78$168
Oct 5, 2026Scholl Hendrik Peter · officer: Chief Medical OfficerSale50$166
Oct 5, 2026Scholl Hendrik Peter · officer: Chief Medical OfficerSale120$165
Oct 5, 2026Scholl Hendrik Peter · officer: Chief Medical OfficerSale24$165
Oct 5, 2026Scholl Hendrik Peter · officer: Chief Medical OfficerSale200$164
Oct 5, 2026Scholl Hendrik Peter · officer: Chief Medical OfficerSale2$170
Oct 5, 2026Scholl Hendrik Peter · officer: Chief Medical OfficerSale14$169
Oct 5, 2026Scholl Hendrik Peter · officer: Chief Medical OfficerSale12$168
Sep 9, 2026Chuang Hao-Yuan · director, officer: Chief Financial OfficerSale1,800$191
Sep 9, 2026Chuang Hao-Yuan · director, officer: Chief Financial OfficerSale6,200$189
Sep 9, 2026Chuang Hao-Yuan · director, officer: Chief Financial OfficerSale1,900$189
Sep 9, 2026Chuang Hao-Yuan · director, officer: Chief Financial OfficerSale3,900$187
Sep 9, 2026Chuang Hao-Yuan · director, officer: Chief Financial OfficerSale4,600$186
Sep 9, 2026Chuang Hao-Yuan · director, officer: Chief Financial OfficerSale2,562$198
Sep 9, 2026Chuang Hao-Yuan · director, officer: Chief Financial OfficerSale4,605$197
Sep 9, 2026Chuang Hao-Yuan · director, officer: Chief Financial OfficerSale4,475$196
Sep 9, 2026Chuang Hao-Yuan · director, officer: Chief Financial OfficerSale4,120$196
Sep 9, 2026Chuang Hao-Yuan · director, officer: Chief Financial OfficerSale2,200$194
Sep 9, 2026Chuang Hao-Yuan · director, officer: Chief Financial OfficerSale4,602$193
Sep 9, 2026Chuang Hao-Yuan · director, officer: Chief Financial OfficerSale3,398$192
Sep 9, 2026Chuang Hao-Yuan · director, officer: Chief Financial OfficerSale3,872$185
Sep 9, 2026Chuang Hao-Yuan · director, officer: Chief Financial OfficerSale3,569$185
Sep 9, 2026Chuang Hao-Yuan · director, officer: Chief Financial OfficerSale3,759$183
Sep 9, 2026Chuang Hao-Yuan · director, officer: Chief Financial OfficerSale2,000$181
Sep 9, 2026Chuang Hao-Yuan · director, officer: Chief Financial OfficerSale1,633$180
Sep 9, 2026Lin Yu-Hsin · director, officer: Chief Executive OfficerSale2,700$198
Sep 9, 2026Lin Yu-Hsin · director, officer: Chief Executive OfficerSale8,752$197
Sep 9, 2026Lin Yu-Hsin · director, officer: Chief Executive OfficerSale6,058$197
Sep 9, 2026Lin Yu-Hsin · director, officer: Chief Executive OfficerSale6,090$196
Sep 9, 2026Lin Yu-Hsin · director, officer: Chief Executive OfficerSale2,400$194
Institutional positioning

13F filings over the trailing two quarters

New 49Increased 54Reduced 35Sold out 21
FilerActionSharesFiled
Darwin Global Management, Ltd.Increased3,077,219Aug 14, 2026
DARWIN GLOBAL MANAGEMENT, LTD.Increased3,057,412May 15, 2026
Paradigm Biocapital Advisors LPIncreased1,232,877Aug 14, 2026
PARADIGM BIOCAPITAL ADVISORS LPNew Position1,114,784May 15, 2026
UBS GROUP AGIncreased768,359May 5, 2026
RTW INVESTMENTS, LPUnchanged715,332Aug 14, 2026
RTW INVESTMENTS, LPUnchanged715,332May 15, 2026
MILLENNIUM MANAGEMENT LLCIncreased570,088May 15, 2026
MILLENNIUM MANAGEMENT LLCReduced494,564Aug 14, 2026
HOLOCENE ADVISORS, LPIncreased494,495May 15, 2026
MAVERICK CAPITAL LTDNew Position396,311Aug 14, 2026
EVENTIDE ASSET MANAGEMENT, LLCIncreased390,829Aug 14, 2026
EVENTIDE ASSET MANAGEMENT, LLCReduced357,650May 15, 2026
DEERFIELD MANAGEMENT COMPANY, L.P.Increased357,199Aug 14, 2026
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)Increased304,013May 15, 2026

Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Oct 5, 2026